Cargando…

Neurofilament Light Chain: Blood Biomarker of Neonatal Neuronal Injury

Background: Neurofilament light chain (NfL) is a highly promising biomarker of neuroaxonal injury that has mainly been studied in adult neurodegenerative disease. Its involvement in neonatal disease remains largely unknown. Our aim was to establish NfL plasma concentrations in preterm and term infan...

Descripción completa

Detalles Bibliográficos
Autores principales: Depoorter, Antoinette, Neumann, Roland P., Barro, Christian, Fisch, Urs, Weber, Peter, Kuhle, Jens, Wellmann, Sven
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6256184/
https://www.ncbi.nlm.nih.gov/pubmed/30524361
http://dx.doi.org/10.3389/fneur.2018.00984
_version_ 1783374096789143552
author Depoorter, Antoinette
Neumann, Roland P.
Barro, Christian
Fisch, Urs
Weber, Peter
Kuhle, Jens
Wellmann, Sven
author_facet Depoorter, Antoinette
Neumann, Roland P.
Barro, Christian
Fisch, Urs
Weber, Peter
Kuhle, Jens
Wellmann, Sven
author_sort Depoorter, Antoinette
collection PubMed
description Background: Neurofilament light chain (NfL) is a highly promising biomarker of neuroaxonal injury that has mainly been studied in adult neurodegenerative disease. Its involvement in neonatal disease remains largely unknown. Our aim was to establish NfL plasma concentrations in preterm and term infants in the first week of life. Methods: Plasma NfL was measured by single molecule array immunoassay in two neonatal cohorts: cohort 1 contained 203 term and preterm infants, median gestational age (GA) 37.9 weeks (interquartile range [IQR] 31.9–39.4), in whom venous and arterial umbilical cord blood was sampled at birth and venous blood at day of life (DOL) 3; cohort 2 contained 98 preterm infants, median GA 29.3 weeks (IQR 26.9–30.6), in whom venous blood was sampled at DOL 7. Results: Median NfL concentrations in venous blood increased significantly from birth (18.2 pg/mL [IQR 12.8–30.8, cohort 1]) to DOL 3 (50.9 pg/mL [41.3–100, cohort 1]) and DOL 7 (126 pg/mL [78.8–225, cohort 2]) (p < 0.001). In both cohorts NfL correlated inversely with birth weight (BW, Spearman's rho −0.403, p < 0.001, cohort 1; R −0.525, p < 0.001, cohort 2) and GA (R −0.271, p < 0.001, cohort 1; R −0.487, p < 0.001, cohort 2). Additional significant correlations were found for maternal age at delivery, preeclampsia, delivery mode, 5-min Apgar, duration of oxygen supplementation, sepsis, and brain damage (intraventricular hemorrhage or periventricular leukomalacia). Multivariable logistic regression analysis identified the independent predictors of NfL in cohort 1 as BW (beta = −0.297, p = 0.003), delivery mode (beta = 0.237, p = 0.001) and preeclampsia (beta = 0.183, p = 0.022) and in cohort 2 as BW (beta = −0.385, p = 0.001) and brain damage (beta = 0.222, p = 0.015). Conclusion: Neonatal NfL levels correlate inversely with maturity and BW, increase during the first days of life, and relate to brain injury factors such as intraventricular hemorrhage and periventricular leukomalacia, and also to vaginal delivery.
format Online
Article
Text
id pubmed-6256184
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-62561842018-12-06 Neurofilament Light Chain: Blood Biomarker of Neonatal Neuronal Injury Depoorter, Antoinette Neumann, Roland P. Barro, Christian Fisch, Urs Weber, Peter Kuhle, Jens Wellmann, Sven Front Neurol Neurology Background: Neurofilament light chain (NfL) is a highly promising biomarker of neuroaxonal injury that has mainly been studied in adult neurodegenerative disease. Its involvement in neonatal disease remains largely unknown. Our aim was to establish NfL plasma concentrations in preterm and term infants in the first week of life. Methods: Plasma NfL was measured by single molecule array immunoassay in two neonatal cohorts: cohort 1 contained 203 term and preterm infants, median gestational age (GA) 37.9 weeks (interquartile range [IQR] 31.9–39.4), in whom venous and arterial umbilical cord blood was sampled at birth and venous blood at day of life (DOL) 3; cohort 2 contained 98 preterm infants, median GA 29.3 weeks (IQR 26.9–30.6), in whom venous blood was sampled at DOL 7. Results: Median NfL concentrations in venous blood increased significantly from birth (18.2 pg/mL [IQR 12.8–30.8, cohort 1]) to DOL 3 (50.9 pg/mL [41.3–100, cohort 1]) and DOL 7 (126 pg/mL [78.8–225, cohort 2]) (p < 0.001). In both cohorts NfL correlated inversely with birth weight (BW, Spearman's rho −0.403, p < 0.001, cohort 1; R −0.525, p < 0.001, cohort 2) and GA (R −0.271, p < 0.001, cohort 1; R −0.487, p < 0.001, cohort 2). Additional significant correlations were found for maternal age at delivery, preeclampsia, delivery mode, 5-min Apgar, duration of oxygen supplementation, sepsis, and brain damage (intraventricular hemorrhage or periventricular leukomalacia). Multivariable logistic regression analysis identified the independent predictors of NfL in cohort 1 as BW (beta = −0.297, p = 0.003), delivery mode (beta = 0.237, p = 0.001) and preeclampsia (beta = 0.183, p = 0.022) and in cohort 2 as BW (beta = −0.385, p = 0.001) and brain damage (beta = 0.222, p = 0.015). Conclusion: Neonatal NfL levels correlate inversely with maturity and BW, increase during the first days of life, and relate to brain injury factors such as intraventricular hemorrhage and periventricular leukomalacia, and also to vaginal delivery. Frontiers Media S.A. 2018-11-20 /pmc/articles/PMC6256184/ /pubmed/30524361 http://dx.doi.org/10.3389/fneur.2018.00984 Text en Copyright © 2018 Depoorter, Neumann, Barro, Fisch, Weber, Kuhle and Wellmann. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Neurology
Depoorter, Antoinette
Neumann, Roland P.
Barro, Christian
Fisch, Urs
Weber, Peter
Kuhle, Jens
Wellmann, Sven
Neurofilament Light Chain: Blood Biomarker of Neonatal Neuronal Injury
title Neurofilament Light Chain: Blood Biomarker of Neonatal Neuronal Injury
title_full Neurofilament Light Chain: Blood Biomarker of Neonatal Neuronal Injury
title_fullStr Neurofilament Light Chain: Blood Biomarker of Neonatal Neuronal Injury
title_full_unstemmed Neurofilament Light Chain: Blood Biomarker of Neonatal Neuronal Injury
title_short Neurofilament Light Chain: Blood Biomarker of Neonatal Neuronal Injury
title_sort neurofilament light chain: blood biomarker of neonatal neuronal injury
topic Neurology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6256184/
https://www.ncbi.nlm.nih.gov/pubmed/30524361
http://dx.doi.org/10.3389/fneur.2018.00984
work_keys_str_mv AT depoorterantoinette neurofilamentlightchainbloodbiomarkerofneonatalneuronalinjury
AT neumannrolandp neurofilamentlightchainbloodbiomarkerofneonatalneuronalinjury
AT barrochristian neurofilamentlightchainbloodbiomarkerofneonatalneuronalinjury
AT fischurs neurofilamentlightchainbloodbiomarkerofneonatalneuronalinjury
AT weberpeter neurofilamentlightchainbloodbiomarkerofneonatalneuronalinjury
AT kuhlejens neurofilamentlightchainbloodbiomarkerofneonatalneuronalinjury
AT wellmannsven neurofilamentlightchainbloodbiomarkerofneonatalneuronalinjury